6 completed. 6 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
| Phase 2 | 2 | Completed 2 |
Follow Amyvid: new trials by email Literature Review of Amyvid trials Research Report on Amyvid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects florbetapir F 18, Flortaucipir F18, Brain PET Scan - Alzheimer's Disease | Phase 2 / Phase 3 | Completed | Avid Radiopharmaceuticals | 383 | 2013-12-01 | 2020-09-22 |
| A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) florbetapir (18F) - Alzheimer's Disease, Mild Cognitive Impairment | Phase 2 / Phase 3 | Completed | Avid Radiopharmaceuticals | 48 | 2012-10-01 | 2013-09-19 |
| Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline florbetapir F 18 - Progressive Cognitive Decline | Phase 3 | Completed | Avid Radiopharmaceuticals | 239 | 2011-07-01 | 2013-03-29 |
| Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) florbetapir F 18 - Alzheimer's Disease | Phase 3 | Completed | Avid Radiopharmaceuticals | 40 | 2011-02-01 | 2022-08-16 |
| Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07 florbetapir F 18 - Alzheimer's Disease | Phase 3 | Completed | Avid Radiopharmaceuticals | 110 | 2010-03-01 | 2025-03-21 |
| Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain florbetapir F 18 - Alzheimer's Disease | Phase 3 | Completed | Avid Radiopharmaceuticals | 226 | 2008-12-01 | 2012-05-22 |
Alzheimer Disease (5) · Cognitive Dysfunction (2)
United States (4) · Japan (1)